Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950138-06-000555
Filing Date
2006-06-30
Accepted
2006-06-30 15:47:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 \ROTH-STARK\2006 FILINGS\JUNE 30 RESPONSE\ jun13g-response.txt SC 13G 12371
  Complete submission text file 0000950138-06-000555.txt   14046
Mailing Address 8900 GLENLYON PARKWAY SUITE 100 BURNABY A1 V5J 5J8
Business Address 8900 GLENLYON PARKWAY SUITE 100 BURNABY A1 V5J 5J8 6046814101
RESPONSE BIOMEDICAL CORP (Subject) CIK: 0000806888 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81850 | Film No.: 06937658
SIC: 8734 Services-Testing Laboratories

Mailing Address 10556 N PORT WASHINGTON RD MEQUON WI 53092
Business Address 4142411810
ROTH MICHAEL (Filed by) CIK: 0001010207 (see all company filings)

Type: SC 13G